Agnico Eagle Mines Ltd vs ARK Genomic Revolution ETF — how do they compare? Agnico Eagle Mines Ltd trades at $185.43 (market cap $92.01B), while ARK Genomic Revolution ETF trades at $44.54. The key difference: Agnico Eagle Mines Ltd pays a 0.99% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Agnico Eagle Mines Ltd nearer its low. Which is the better fit depends on your goals.
| AEM | ARKG | |
|---|---|---|
Market Cap | $92.01B | — |
Sector | Basic Materials | Sector/Thematic |
52-Week High | $252.19 | $44.55 |
52-Week Low | $130.23 | $24.02 |
Enterprise Value | $88.85B | — |
Dividend Yield | 0.99% | — |
Signals from Pluang's Aura AI — not financial advice
Agnico Eagle Mines (AEM) trades at $185.82, up 2.96% on the day, reflecting strong momentum amid record gold prices and robust earnings. The stock exhibits a bullish technical setup with support near $180 and resistance at $186, while fundamentals are supported by a 37.5% net income margin and consistent earnings beats. Recent news highlights operational strength, with Q2 2026 EPS of $3.05 surpassing estimates and management projecting 20-30% production growth organically.
Outlook remains positive given analyst consensus and gold's uptrend, but rising unit costs and production challenges pose risks. With a $219.63 average price target implying 18% upside, AEM offers growth exposure to gold, though investors should monitor cost inflation and execution of expansion plans.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →